MACITENTAN
| Brand name | MACITENTAN |
|---|---|
| Active ingredient | MACITENTAN |
| Strength | 10MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | April 2021 |
| Marketing status | RX |
| Code | Expires |
|---|---|
| PC | December 2026 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.